Late treatment study
et al., medRxiv doi:10.1101/2020.03.22.20040758 (Preprint)
Efficacy of hydroxych loroquine in patients with COVID-19: results of a randomized clinical trial
62 patients. RCT showing significantly faster recovery with HC
Q. 13% progressed to severe cases in the control group, versus 0% for the treatment group. Significant improvement seen in pneumonia on chest CT for 61% of treated patients and 16% of control patients.
no improvement in pneumonia, ↓57.0%, p=0.04, risk of no improvement in pneumonia at day 6
Please send us corrections, updates, or comments.